These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36149336)

  • 1. Comparison of the value of conventional two-dimensional ultrasound, contrast-enhanced ultrasound and MSCT in early diagnosis of small hepatocellular carcinoma.
    Xie F; Hong Y; Sun X; Wang B; Meng Q; Guo J; Huang B
    Minerva Gastroenterol (Torino); 2023 Mar; 69(1):162-165. PubMed ID: 36149336
    [No Abstract]   [Full Text] [Related]  

  • 2. Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS working group.
    Lyshchik A; Kono Y; Dietrich CF; Jang HJ; Kim TK; Piscaglia F; Vezeridis A; Willmann JK; Wilson SR
    Abdom Radiol (NY); 2018 Apr; 43(4):861-879. PubMed ID: 29151131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-Enhanced Ultrasound of Focal Liver Lesions.
    Chaubal N; Joshi M; Bam A; Chaubal R
    Semin Roentgenol; 2016 Oct; 51(4):334-357. PubMed ID: 27743569
    [No Abstract]   [Full Text] [Related]  

  • 4. Contrast-enhanced ultrasound has come of age.
    Albrecht T
    Ultraschall Med; 2008 Sep; 29 Suppl 4():S187. PubMed ID: 18833496
    [No Abstract]   [Full Text] [Related]  

  • 5. Ultrasound Evaluation in Patients at Risk for Hepatocellular Carcinoma.
    Fetzer DT; Rodgers SK; Seow JH; Dawkins AA; Joshi G; Gabriel H; Kamaya A
    Radiol Clin North Am; 2019 May; 57(3):563-583. PubMed ID: 30928078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of contrast-enhanced ultrasound in the detection of focal liver leasions.
    Solbiati L; Tonolini M; Cova L; Goldberg SN
    Eur Radiol; 2001; 11 Suppl 3():E15-26. PubMed ID: 11793049
    [No Abstract]   [Full Text] [Related]  

  • 7. [Early diagnosis of small hepatocellular carcinoma by new contrast-enhanced ultrasound technique].
    Chen MH; Dai Y; Yan K; Fan ZH; Wu W; Wang YB; Yin SS; Yang W; Li JY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):458-62. PubMed ID: 16224512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of focal liver lesions with contrast-enhanced ultrasound.
    Nicolau C; Catalá V; Brú C
    Eur Radiol; 2003 Nov; 13 Suppl 3():N70-8. PubMed ID: 15015885
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical value of dynamic 3-dimensional contrast-enhanced ultrasound imaging for the assessment of hepatocellular carcinoma ablation.
    Wang Y; Jing X; Ding J
    Clin Imaging; 2016; 40(3):402-6. PubMed ID: 27133676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic efficacy of ultrasound in hepatocellular carcinoma diagnosis.
    Kee KM; Lu SN
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):277-279. PubMed ID: 28162003
    [No Abstract]   [Full Text] [Related]  

  • 11. Predictive Value of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Early Recurrence of Hepatocellular Carcinoma after Surgical Resection.
    Wang Y; Liao J; Qi W; Xie L; Li Y
    Ultrasound Med Biol; 2016 May; 42(5):1042-8. PubMed ID: 26803390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced ultrasonography: a recent application for the diagnosis and treatment of hepatocellular carcinoma.
    Maruyama K; Yoshikawa M; Yokosuka O
    JNMA J Nepal Med Assoc; 2008; 47(171):156-66. PubMed ID: 19079385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Suspected Hepatocellular Carcinoma with Contrast-Enhanced Ultrasound.
    Squires JH; Bill A; Thieret J; Squires JE
    J Pediatr; 2017 Mar; 182():398-398.e1. PubMed ID: 28063693
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of contrast-enhanced ultrasound in the characterisation of focal liver lesions.
    Leen E
    Eur Radiol; 2001; 11 Suppl 3():E27-34. PubMed ID: 11793050
    [No Abstract]   [Full Text] [Related]  

  • 15. Contribution of Contrast-Enhanced Sonography With Perfluorobutane Microbubbles for Diagnosis of Recurrent Hepatocellular Carcinoma.
    Shagdarsuren B; Tamai H; Shingaki N; Mori Y; Maeshima S; Nuta J; Maeda Y; Moribata K; Niwa T; Deguchi H; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
    J Ultrasound Med; 2016 Jul; 35(7):1383-91. PubMed ID: 27208196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma and liver metastases.
    Seitz K
    Ultraschall Med; 2005 Aug; 26(4):267-9. PubMed ID: 16123919
    [No Abstract]   [Full Text] [Related]  

  • 17. Grading of hypervascular hepatocellular carcinoma using late phase of contrast enhanced sonography - a prospective study.
    Boozari B; Soudah B; Rifai K; Schneidewind S; Vogel A; Hecker H; Hahn A; Schlue J; Dietrich CF; Bahr MJ; Kubicka S; Manns MP; Gebel M
    Dig Liver Dis; 2011 Jun; 43(6):484-90. PubMed ID: 21377941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-Enhanced Ultrasound Findings and Differential Diagnosis of Hepatic Epithelioid Angiomyolipoma Compared with Hepatocellular Carcinoma.
    Huang Z; Wu X; Li S; Li K
    Ultrasound Med Biol; 2020 Jun; 46(6):1403-1411. PubMed ID: 32165015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation for hepatocellular carcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in guiding and assessing early therapeutic response and short-term follow-up results.
    Du J; Li HL; Zhai B; Chang S; Li FH
    Ultrasound Med Biol; 2015 Sep; 41(9):2400-11. PubMed ID: 26055968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravenous ultrasound contrast agent, Levovist].
    Kudo M
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():306-13. PubMed ID: 11761963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.